Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.
about
Genetics of Common Antipsychotic-Induced Adverse EffectsElectronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts.HGVS Recommendations for the Description of Sequence Variants: 2016 Update.Leveraging genomic data in smoking cessation trials in the era of Precision Medicine: Why and how.Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative ProjectStandardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)Prediction of CYP2D6 phenotype from genotype across world populationsMultidisciplinary model to implement pharmacogenomics at the point of care.Association between CYP2D6 Genotypes and the Risk of Antidepressant Discontinuation, Dosage Modification and the Occurrence of Maternal Depression during Pregnancy.Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects.Requirements for comprehensive pharmacogenetic genotyping platforms.Principles and Recommendations for Standardizing the Use of the Next-Generation Sequencing Variant File in Clinical Settings.Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review.Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy.Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio Sequencing.Ethical considerations surrounding germline next-generation sequencing of children with cancer.External quality assessment for laboratory testing of HLA-B*15:02 allele in relation to carbamazepine therapy.A rare disorder or not? How a child with jaundice changed a nationwide regimen in the Netherlands.Constellation: a tool for rapid, automated phenotype assignment of a highly polymorphic pharmacogene, CYP2D6, from whole-genome sequences.Impact of CYP2D6 on venlafaxine metabolism in Trinidadian patients with major depressive disorder.Pharmacogenomic testing in child and adolescent psychiatry: An evidence-based review.The challenges of implementing pharmacogenomic testing in the clinic.Research directions in the clinical implementation of pharmacogenomics - An Overview of US programs and projects.Pharmacogenetic Decision Support Tools: A New Paradigm for Late-Life Depression?From pharmacogenetics to imaging pharmacogenetics: elucidating mechanisms of antidepressant response.Educating patients and providers through comprehensive pharmacogenetic test reports.Frequency of CYP2D6 Alleles Including Structural Variants in the United States.
P2860
Q28072893-B2234433-39A4-484C-B6E4-BEBF4C4DC582Q30234897-491AE7A7-9DEF-4D93-9F7F-3583691C20E0Q35941614-5F738129-4D7B-4350-9B64-9E98AC4F696CQ36370325-131948AE-0011-4386-8426-E3A06DCF6327Q36414582-980C3ED7-2D37-42B4-BD6E-F0231469E58CQ37597647-C3591D75-5EDD-46CD-8F42-0275772E7B5FQ37625633-81877384-5663-4F68-8BCE-02940FCA48B5Q37716307-3EE90F9A-82B2-43E9-9FD0-5F2AEDB1A874Q38645670-7C12C908-BCA3-45A2-96DE-1D1849B7E806Q38853651-E62FB11B-40F8-4F3A-A464-D6A46E896E85Q38859829-988E33CA-850C-4008-A077-2C6B0A8737E9Q38896358-A0FD2967-E419-4E4B-A005-A860671581A0Q38983589-6B6FBE1B-981D-4337-B876-1A953BCA87C5Q38998163-3F2147FB-367A-4B02-85DF-F182134D61BBQ39043568-45527914-9609-4559-BCB1-72FB16458963Q39235246-67839C79-D398-4D8F-A20E-99E1F69C353CQ39261119-B84A3119-5E49-4680-95C5-DEC362D4FFFBQ42055039-767B95B8-DEB0-4A08-9184-FF66C078B51EQ47099388-C274D4BC-B1EE-4303-AF69-DAB1B66FED9BQ47657184-8114B320-26E0-4FE6-8436-867EC6C9C378Q47657960-3E5BCA21-E19C-49AA-B03B-1214F2DBE9F1Q47929031-940ABB53-1D4A-429B-82F1-7DB675BA74D0Q49822573-A1C8101B-0D8D-4337-A818-06726DBFA442Q50075076-C87CCD39-4AF6-47B9-BF8E-69433C2B097AQ52837901-E1B85071-A953-42A8-96FE-B4E27A6E0FEFQ53734801-5D27673F-5F51-47C1-8B8E-9D12A51420ADQ55087082-ED6CC237-93EA-4D61-B2A7-D73B4FAB914A
P2860
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacogenetic allele nomencl ...... ons for test result reporting.
@ast
Pharmacogenetic allele nomencl ...... ons for test result reporting.
@en
type
label
Pharmacogenetic allele nomencl ...... ons for test result reporting.
@ast
Pharmacogenetic allele nomencl ...... ons for test result reporting.
@en
prefLabel
Pharmacogenetic allele nomencl ...... ons for test result reporting.
@ast
Pharmacogenetic allele nomencl ...... ons for test result reporting.
@en
P2093
P2860
P50
P356
P1476
Pharmacogenetic allele nomencl ...... ions for test result reporting
@en
P2093
Al Del Tredici
C Bruckner
D A Nickerson
D Flockhart
D J Müller
D R Maglott
G A McMillin
P2860
P304
P356
10.1002/CPT.280
P407
P577
2015-11-20T00:00:00Z